Your request to link to MMDB for Urokinase-type plasminogen activator/surface receptor
MMDB Description | |
---|---|
17489 | Structural Basis for Selectivity of a Small Molecule, S1- Binding, Sub-micromolar Inhibitor of Urokinase Type Plasminogen Activator |
17490 | Structural Basis for Selectivity of a Small Molecule, S1- Binding, Sub-micromolar Inhibitor of Urokinase Type Plasminogen Activator |
17491 | Structural Basis for Selectivity of a Small Molecule, S1- Binding, Sub-micromolar Inhibitor of Urokinase Type Plasminogen Activator |
17492 | Structural Basis for Selectivity of a Small Molecule, S1- Binding, Sub-micromolar Inhibitor of Urokinase Type Plasminogen Activator |
13454 | Urokinase Plasminogen Activator B-chain Inhibitor Complex |
16693 | Urokinase Plasminogen Activator B-chain-benzamidine Complex |
16694 | Urokinase Plasminogen Activator B-chain-amiloride Complex |
17023 | Urokinase Plasminogen Activator B Chain-uki-1d Complex |
14861 | Crystal Structure of Human Microurokinase in Complex With 2- Amino-5-hydroxy-benzimidazole |
18534 | a Novel Serine Protease Inhibition Motif Involving a Multi-centered Short Hydrogen Bonding Network at the Active Site |
18535 | a Novel Serine Protease Inhibition Motif Involving a Multi- Centered Short Hydrogen Bonding Network at the Active Site |
18536 | a Novel Serine Protease Inhibition Motif Involving a Multi-centered Short Hydrogen Bonding Network at the Active Site |
19157 | Engineering Inhibitors Highly Selective for the S1 Sites of Ser190 Trypsin-like Serine Protease Drug Targets |
72139 | Engineering Inhibitors Highly Selective for the S1 Sites of Ser190 Trypsin-like Serine Protease Drug Targets |
19159 | Engineering Inhibitors Highly Selective for the S1 Sites of Ser190 Trypsin-like Serine Protease Drug Targets |
19160 | Engineering Inhibitors Highly Selective for the S1 Sites of Ser190 Trypsin-like Serine Protease Drug Targets |
19161 | Engineering Inhibitors Highly Selective for the S1 Sites of Ser190 Trypsin-like Serine Protease Drug Targets |
19162 | Engineering Inhibitors Highly Selective for the S1 Sites of Ser190 Trypsin-like Serine Protease Drug Targets |
19386 | Engineering Inhibitors Highly Selective for the S1 Sites of Ser190 Trypsin-like Serine Protease Drug Targets |
56549 | Sequential 1H NMR Assignments and Secondary Structure of the Kringle Domain From Urokinase |
50134 | LMW U-pa Structure Complexed With Egrcmk (Glu-gly-arg Chloromethyl Ketone) |
23914 | Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-directed Serine Protease Inhibitors |
29254 | Dissecting and Designing Inhibitor Selectivity Determinants at the S1 Site Using an Artificial Ala190 Protease (Ala190 Upa) |
29255 | Dissecting and Designing Inhibitor Selectivity Determinants at the S1 Site Using an Artificial Ala190 Protease (Ala190 Upa) |
29256 | Dissecting and Designing Inhibitor Selectivity Determinants at the S1 Site Using an Artificial Ala190 Protease (Ala190 Upa) |
24716 | Substituted 2-naphthamidine Inhibitors of Urokinase |
24717 | Substituted 2-naphthamidine Inhibitors of Urokinase |
24718 | Substituted 2-naphthamidine Inhibitors of Urokinase |
24719 | Substituted 2-naphthamidine Inhibitors of Urokinase |
24720 | Substituted 2-naphthamidine Inhibitors of Urokinase |
24721 | Substituted 2-naphthamidine Inhibitors of Urokinase |
28236 | Urokinase Plasminogen Activator B-chain-j435 Complex |
27438 | Substituted 2-naphthamidine Inhibitors of Urokinase |
27439 | Substituted 2-naphthamidine Inhibitors of Urokinase |
27440 | Substituted 2-naphthamidine Inhibitors of Urokinase |
30010 | Substituted 2-naphthamadine Inhibitors of Urokinase |
57580 | Solution Structure of the Amino Terminal Fragment of Urokinase-type Plasminogen Activator |
28438 | Urokinase Plasminogen Activator B-chain-jt464 Complex |
28439 | Urokinase Plasminogen Activator B-chain-jt463 Complex |
64469 | Urokinase Type Plasminogen Activator |
64470 | Urokinase Type Plasminogen Activator |
64471 | Urokinase Type Plasminogen Activator |
64472 | Urokinase Type Plasminogen Activator |
64473 | Urokinase Type Plasminogen Activator |
64474 | Urokinase Type Plasminogen Activator |
37726 | Structure of Human Urokinase Plasminogen Activator in Complex With Urokinase Receptor and an Anti-upar Antibody at 1.9 a |
42920 | Crystal Structure of the Free Aminoterminal Fragment of Urokinase Type Plasminogen Activator (Atf) |
43398 | Crystal Structure of Atf-urokinase Receptor Complex |
59154 | NEW Pharmacophore for Serine Protease Inhibition Revealed by Crystal Structure of Human Urokinase-type Plasminogen Activator Complexed With a Cyclic Peptidyl Inhibitor, Upain-1 |
61484 | Crystal Structure and Binding Epitopes of Urokinase-type Plasminogen Activator (C122an145q) in Complex With Inhibitors |
61485 | Crystal Structure and Binding Epitopes of Urokinase-type Plasminogen Activator (C122an145qs195a) in Complex With Inhibitors |
61486 | Crystal Structure and Binding Epitopes of Urokinase-type Plasminogen Activator (C122an145qs195a) in Complex With Inhibitors |
60287 | Urokinase Plasminogen Activator B-chain-gppe Complex |
62018 | Fragment-based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-type Plasminogen Activator |
62019 | Fragment-based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-type Plasminogen Activator |
62020 | Fragment-based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-type Plasminogen Activator |
62021 | Fragment-based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-type Plasminogen Activator |
62022 | Fragment-based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-type Plasminogen Activator |
62023 | Fragment-based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-type Plasminogen Activator |
62542 | Urokinase-type Plasminogen Activator Inhibitor Complex With a 1-(7-sulphoamidoisoquinolinyl)guanidine |
63295 | Structure of Urokinase Receptor, Urokinase and Vitronectin Complex |
63296 | Structure of Urokinase Receptor, Urokinase and Vitronectin Complex |
77351 | LOW Molecular Weigth Human Urokinase Type Plasminogen Activator 2-[6- (3'-aminomethyl-biphenyl-3-yloxy)-4-(3-dimethylamino-pyrrolidin-1- Yl)-3,5-difluoro-pyridin-2-yloxy]-4-dimethylamino-benzoic Acid Complex |
78465 | Crystal Structures of Urokinase-type Plasminogen Activator in Complex With 4-(aminomethyl) Benzoic Acid and 4- (Aminomethyl-phenyl)-methanol |
78468 | Crystal Structures of Urokinase-type Plasminogen Activator in Complex With 4-(aminomethyl) Benzoic Acid and 4- (Aminomethyl-phenyl)-methanol |
78469 | The Crystal Structures of 2-aminobenzothiazole-based Inhibitors in Complexes With Urokinase-type Plasminogen Activator |
81295 | Crystal Structure of Complex of Urokinase and a Upain-1 Variant(w3a) in Ph4.6 Condition |
81621 | The Complex Crystal Structure of Urokianse and 2- Aminobenzothiazole |
90937 | The Complex Crystal Structure of Urokianse and 5-nitro-1h-indole-2- Amidine |
87648 | Crystal Structure of a Michaelis Complex Between Plasminogen Activator Inhibitor-1 and Urokinase-type Plasminogen Activator |